Fig. 10From: CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinomaCorrelations of CD5L, LCAT, and CDC20 with MKI67, APF, and ALB in HCC. A–C The correlations of CD5L, LCAT and CDC20 with MKI67 expression in HCC. D–F The correlations of CD5L, LCAT and CDC20 expressions with AFP expression (tissue AFP) in HCC. G–I The correlations of CD5L, LCAT and CDC20 expressions with serum AFP (ng/ml) in HCC. J–L The correlations of CD5L, LCAT and CDC20 expressions with ALB expression (tissue ALB) in HCC. M–O The correlations of CD5L, LCAT and CDC20 expressions with serum ALB (g/l) in HCC. For G–I, the serum AFP level was log2(x) transformed. Spearman correlation analysis was used and p < 0.05 was considered significantBack to article page